packageSacituzumabGovitecan

sacituzumab govitecan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sacituzumab govitecan is an antibody-drug conjugate used to treat breast cancer, including triple-negative breast cancer. It is approved and authorised for use in the European Union, and remains under investigation for other uses.

Summary written by glm-5.3-flash from Wikidata Q23901469 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sacituzumab govitecan
ATC codes:L01FX17
DrugBank:DB12893
Wikidata:Q23901469
molar mass:1601.8 g/mol (Drugs.Common 25.09, not verified)
logP:-3.3 (Drugs.Common 25.09, not verified)

Metabolites

FreeSN38free SN-38392.411 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
FreeSN38metabolite: free SN-38